HERCULES CAPITAL, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.07 USD | +0.63% |
|
+3.30% | +14.40% |
| Apr. 03 | KARL STORZ SE & Co. KG entered into an agreement to acquire Asensus Surgical, Inc. for $100 million. | CI |
| Mar. 26 | Bluebird bio to Restate Financial Statements; Shares Fall | MT |
Strengths
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- The company's attractive earnings multiples are brought to light by a P/E ratio at 9.32 for the current year.
- The company is one of the best yield companies with high dividend expectations.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- The company's earnings growth outlook lacks momentum and is a weakness.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Investment Management & Fund Operators
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| +14.40% | 3.06B | B- | ||
| +31.41% | 12.02B | - | - | |
| +2.96% | 1.42B | D+ | ||
| -8.46% | 1.22B | - | - | |
| +1.15% | 616M | - | ||
| -10.84% | 579M | - | B+ | |
| +35.79% | 577M | - | D+ | |
| -4.17% | 492M | - | - | |
| +33.85% | 488M | - | - | |
| +3.90% | 304M | - | - |
Investor Rating
Trading Rating
ESG Refinitiv
Financials
Sales growth
Earnings Growth
EBITDA / Sales
-
Profitability
Finances
-
Valuation
P/E ratio
EV / Sales
-
Price to Book
Price to Free Cash Flow
-
Yield
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion
Business Predictability
Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
Environment
Emissions
Innovation
Use of resources
Governance
CSR Strategy
Management
Shareholders
Controversy
Controversy
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- HTGC Stock
- Ratings Hercules Capital, Inc.
